A review of glutamate receptors I: Current understanding of their biology

Journal of Toxicologic Pathology

Volumn 21, Issue 1, 2008, Pages 25-51

  Rousseaux, Colin G ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b NONE   (Canada)

Author keywords

AMPA; GABA; Glutamate receptors; Glutamte; Glycine; Ionotropic; Metabotropic; NMDA; Review

Indexed keywords

EID: 42949095600     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.21.25     Document Type: Review

References (397)

1. Sabbatini RME. Neurons and synapses. Brain and Mind. 17: 1-6. 2003.
2. Florey E. An inhibitory and an excitatory factor of mammalian central nervous system, and their action on a single sensory neuron. Arch Int Physiol. 62: 33-53. 1954.
3. Kuffler SW. Mechanisms of activation and motor control of stretch receptors in lobster and crayfish. J Neurophysiol. 17: 558-574. 1954.
4. Nicoll RA and Malenka RC. Contrasting properties of two forms of long-term potentiation in the hippocampus. Nature. 377: 115-118. 1995.
5. Scallet AC, Schmued LC, and Johannessen JN. Neurohistochemical biomarkers of marine neurotoxicant, domoic acid. Neurotoxicol Teratol. 27: 745-752. 2005.
6. Bowery NG and Smart TG. GABA and glycine as neurotransmitters: a brief history. Br J Pharmacol. 147: S109-S119. 2006.
7. Bliss TVP and Collingridge GL. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature. 361: 31-39. 1993.
8. Chapman PF, Kairiss EW, Keenan CL, and Brown TH. Long-term synaptic potentiation in the amygdala. Synapse. 6: 271-278. 1990.
9. Bruno V, Copani A, Battagli G, Raffaele R, Shinozaki H, and Nicoletti F. Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death. Eur J Pharmacol. 256: 109-112. 1994.
10. Masu M, Tanabe Y, Tsuchida K, Shigemoto I, and Nakanishi S. Sequence and expression of a metabotropic glutamate receptor. Nature. 349: 760-765. 1991.
11. Meir A, Ginsberg S, Butkevich A, Kachalasky SG, Kaiserman I, Ahdut R, Demirgoren S, and Rahamimoff R. Ion channels in presynaptic nerve terminals and control of transmitter release. Physiol Rev. 79: 1019-1088. 1999.
12. Raiteri M. Functional pharmacology in human brain. Pharmacol Rev. 58: 162-193. 2006.
13. Watkins JC and Jane DE. The glutamate story. Br J Pharmacol. 147 (Suppl 1): S100-108. 2006.
14. Gronier B and Debonnel G. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems. Eur J Pharmacol. 368: 183-196. 1999.
15. Guitart X, Méndez R, Ovalle S, Andreu F, Carceller A, Farrd AJ, and Zamanillo D. Regulation of ionotropic glutamate receptor subunits in different rat brain areas by a preferential sigma(1) receptor ligand and potential atypical antipsychotic. Neuropsychopharmacology. 23: 539-546. 2000.
16. Bermack JE and Debonnel G. The role of sigma receptors in depression. J Pharmacol Sci. 97: 317-336. 2005.
17. Dong J, Bloom JD, Goncharov V, Chattopadhyay M, Millhauser GL, Lynn DG, Scheibel T, and Lindquist S. Probing the role of PrP repeats in conformational conversion and amyloid assembly of chimeric yeast prions. J Biol Chem. 282: 34204-34212. 2007.
18. Chittajallu R, Vignes M, Dev KK, Barnes JM, Collingridge GL, and Henley JM. Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Nature. 379: 78-81. 1996.
19. Swanson CJ, Bures M, Johnson MP, Linden AM, Monn JA and Schoepp DD. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov. 4: 131-144. 2005.
20. Dingledine R, Borges K, Bowie D, and Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev. 51: 7-61. 1999.
21. Dingledine R and McBain CJ. Excitatory amino acids transmitters. In: Basic Neurochemistry. GJ Siegal, RW Agronoff, BW Albers and PB Molinof (eds). Raven Press, New York. 367-387. 1994.
22. Mueller R, Gill S, and Pulido O. The monkey (Macaca fascicularis) heart neural structures and conducting system: an immunochemical study of selected neural biomarkers and glutamate receptors. Toxicol Pathol. 31: 227-234. 2003.
23. Gasic GP and Hollmann M. Molecular neurobiology of glutamate receptors. Ann Rev Physiol. 54: 507-536. 1992.
24. Hollmann M and Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci. 17: 31-108. 1994.
25. Asztely F and Gustafasson B. Ionotropic glutamate receptors: Their possible role in the expression of hippocampal synaptic plasticity. Mol Neurobiol. 12: 1-11. 1996.
26. Lipton SA. Prospects for clinically tolerated NMDA antagonists: Open-channel blockers and alternative redox states of nitric oxide. Trends Neuorsci. 16: 527-532. 1993.
27. Lipton SA and Gendelman HE. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med. 332: 934-940. 1995.
28. Lipton SA and Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 330: 613-622. 1994.
29. Meldrum BS. The role of glutamate in epilepsy and other central nervous disorders. Neurology. 44: 14-23. 1994.
30. Miller S, Kesslak JP, Romano C, and Cotman CW. Roles of metabotropic receptors in brain plasticity and pathology. Ann NY Acad Sci. 757: 460-474. 1996.
31. Miller HP, Levey AI, Rothstein JD, Tzingounis AV, and Conn PJ. Alterations in glutamate transporter protein levels in kindling-induced epilepsy. J Neurochem. 68: 1564-1570. 1997.
32. Ozawa S, Kamiya H, and Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog Neurobiol. 54: 581-618. 1998.
33. Schoepp DD. Novel function for subtypes of metabotropic glutamate receptors. Neurochem Int. 24: 439-449. 1994.
34. Choi DW. Excitotoxic cell death. J Neurobiol. 23: 1261-1276. 1992.
35. Ozono R, O'Connell DP, Vaughan C, Botkin SJ, Walk SF, Felder RA, and Carey RM. Expression of the subtype 1A dopamine receptor in the rat heart. Hypertension. 27: 693-703. 1996.
36. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, and Nicotera P. Glutamate induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15: 961-973. 1995.
37. Lipton SA and Nicotera P. Calcium, free radicals and excitotoxins in neuronal apoptosis. Cell Calcium. 223: 165-171. 1998.
38. 2++ calmodulin-stimulated adenylate cyclase in rat brain (review). Int J Mol Med. 6: 377-389. 2000.
39. Rosin C, Bates TE, and Skaper SD. Excitatory amino acid induced oligdendrocyte death in vitro: receptor-dependent and -independent mechanisms. J Neurochem. 90: 1173-1185. 2004.
40. Truong DD, Bhidayasiri R, and Wolters E. Management of non-motor symptoms in advanced Parkinson disease. J Neurol Sci. 266: 216-218. 2008.
41. Underhill SM and Goldberg MP. Hypoxic injury of isolated axons is dependent of ionotropic glutamate recptors. Neurobiol Dis. 25: 284-290. 2007.
42. Bruni JE, Bose R, Pinsky C, and Gavin G. Circumventricular organ origin of domoic acid-induced neuropathology and toxicology. Brain Res Bull. 26: 419-424. 1991.
43. Price MT, Olney JW, and Cicero TJ. Acute elevations of serum luteinizing hormone induced by kainic acid, N-methyl aspartic acid, or homocysteic acid. Neuroendocrinol. 26: 352-358. 1978.
44. Smith QR. Transport of glutamate and other amino acids at the blood brain barrier. J Nutr. 130: 1016S-1022S. 2000.
45. Choi DW. Glutamte neurotoxicity and diseases of the nervous system. Neuron. 1: 623-634. 1988.
46. Meldrum BS. Glutarnate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr. 130: 1007S-1015S. 2000.
47. Gill SS and Pulido OM. Glutamate receptors in peripheral tissues: current knowledge, future research, and implications for toxicology. Toxicol Pathol. 29: 208-223. 2001.
48. Obrenovitch TP and Urenjak J. Altered glutamatergic transmission in neurological disorders: From high extracellular glutamate to excessive synaptic efficacy. Prog Neurobiol. 51: 39-87. 1997.
49. Parsons CG, Danysz W, and Quack G. Glutamate in CNS Disorders as a target for drug development. An update. Drug News Perspect. 11: 523-569. 1998.
50. Singh P, Mann KA, Mangat HK, and Kaur G. Prolonged glutamate excitotoxicity: effects on mitochondrial antioxidants and antioxidant enzymes. Mol Cell Chem. 234: 139-145. 2003.
51. Boldyrev A, Bulygina E, Makhro A. Glutamate receptors modulate oxidative stress in neuronal cells. Neurotox. Res. 6: 581-587. 2004.
52. South J. Tired of being tired? Anti-Aging Bull. 4: 3-21. 1999.
53. Li S and Stys PK. Mechanisms of ionotropic glutamate receptor-mediated excitottoxicity in isolated spinal cord white matter. J Neurosci. 20: 1190-1198. 2000.
54. Conn PJ and Pin JP. Pharmacology and functions of metabotrophic receptors. Ann Rev Pharmacol Toxicol. 37: 205-237. 1997.
55. Cunningham MD, Ferkany JW, and Enna SJ. Excitatory amino acid receptors: A gallery of new targets for pharmacological intervention. Life Sci. 54: 135-148. 1994.
56. Ozawa S and Rossier J. Molecular basis for functional differences of AMPA-subtype glutamate receptors. News Physiol Soc. 11: 77-82. 1996.
57. Rothman SM and Olney JW. Excitotoxicity and the NMDA receptor. Trends Neurosci. 10: 299-302. 1987.
58. Choi DW. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci 18: 58-60. 1995.
59. Gill SS, Mueller RW, McGuire PR, and Pulido OM. Potential target sites in peripheral tissues for excitatory neurotransmission and excitotoxicity. Toxicol Pathol. 28: 277-284. 2004
60. Skerry TM and Genever PG. Glutamate signalling in non-neuronal tissues. Trends Pharmacol Sci. 4: 174-181. 2001.
61. Meldrum BS. Amino acids as dietary excitotoxins: a contribution to understanding neurodegenerative disorders. Brain Res Rev. 18: 293-314. 1993.
62. Iverson F, Truelove J, Tryphonas L, and Nera EA. The toxicology of domoic acid administered systemically to rodents and primates. Can Dis Wkly Rep. 16 (Suppl 1E): 15-8; 18-19. 1990
63. Krogsgaard-Larsen P and Hansen JJ. Naturally-occurring excitatory amino acids as neurotoxins and leads in drug design. Toxicol Lett. 64-65: 409-416. 1992.
64. Peng YG, Taylor TB, Finch RE, Switzer RC, and Ramsdell JS. Neuroexcitatory and neurotoxic actions of the amnesic shellfish poison, domoic acid. Neuroreport. 5: 981-985. 1994.
65. Perl TM, Bédard L, Kosatsky T, Hockin JC, Todd EC, McNutt LA, and Remis RS. Amnesic shellfish poisoning: a new clinical syndrome due to domoic acid. Can Dis Wkly Rep. 16 (Suppl 1E): 7-8. 1990.
66. Truelove J, Mueller R, Pulido O, and Iverson F. Subchronic toxicity study of domoic acid in the rat. Food Chem Toxicol. 34: 525-529. 1996.
67. Sureda F, Copani A, Bruno V, Knopel T, Meltzger G, and Nicoletti F. Metabotropic glutamate receptor agonists stimulate polyphosphoinositide hydrolysis in primary cultures of rat hepatocytes. Eur J Pharmacol. 338: R1-R2. 1997.
68. Teitelbaum J, Zatorre RS, Carpenter S, Gendron D, Evans AC, Gjedde A, and Cashman NR. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N Engl J Med. 322: 1781-1787. 1990.
69. Tryphonas L, Truelove J, Iverson F, Todd ECD, and Nera EA. Neuropathology of experimental domoic acid noisoning in non-human primates and rats. Can Dis Wkly Rep. 16 (Suppl 1E): 75-81. 1990.
70. Chandrasekaran A, Ponnambalam G, and Kaur C. Domoic acid-induced neurotoxicity in the hypocampus of adult rats. Neurotox. Res. 6: 105-117. 2004.
71. Zautcke JL, Schwartz JA, and Mueller EJ. Chinese restaurant syndrome: A review. Ann Emerg Med. 15: 1210-1213. 1986.
72. Silvagni PA, Lowenstine LJ, Spraker T, Lipscomb TP and Gulland FMD. Pathology of domoic acid toxicity in California sea lions (Zalophus californianus). Vet Pathol. 42: 184-191. 2005.
73. Danysz W, Parsons CG, Bresink I, and Quack G. Glutamate in CNS disorders - A revived target for drug development. Drug News Perspect. 8: 261-277. 1995.
74. Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol. 31: 119-130. 1992.
75. Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol. 38: 357-366. 1995.
76. Beal MF. Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis. Ann Neurol. 44 (Suppl 1): S110-S114. 1998.
77. Blaylock R. Excitotoxins. Santa Fe: Health Press, 1997.
78. Blaylock RL. Excitotoxitity: a possible central mechanism in fluoride neurotoxicity. Fluoride. 37: 301-314. 2004.
79. Starr MS. Antiparkinsonian actions of glutamate antagonists - alone and with 1-DOPA: a review of evidence and suggestions for possible mechanisms. J Neural Transm-Parkinsons. 10: 141-185, 1995.
80. Plaitakis A, Fesdjian CO, and Shashidharan P. Glutamate antagonists in amyotrophic lateral sclerosis: a review of their therapeutic potential. CNS Drugs. 5: 437-456. 1996.
81. Shaw PJ and Ince PG. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J Neurol. 244: S3-S14. 1997.
82. Trujillo KA and Akil H. Excitatory amino acids and drugs of abuse: A role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence. Drug Alcohol Depend. 38: 139-154. 1995.
83. Dickenson A. Mechanisms of central hypersensitivity: Excitatory amino acid mechanisms and their control. In: Pharmacology of Pain, A Dickenson and JM Besson (eds). Springer-Verlag, Berlin. 167-210. 1997.
84. Sanabria ER, Pereira MF, Dolnikoff MS, Andrade IS, Ferreira AT, Cavalheiro EA, and Fernandes MJ. Defficit in hypocampal long-term potentiation in monosodium glutamate-treated rats. Brain Res Bull. 59: 47-51. 2002.
85. Freeman M. Reconsiderating the effects of monosodium glutamate: a literature review. J Amer Acad Nurse Pract. 18: 482-486. 2006.
86. Massey SC. Cell types using glutamate as a neurotransmitter in the vertebrate retina. Progr Retinal Res. 9: 399-425. 1990.
87. Erulkar SD. Chemically mediated synaptic transmission: an overview. In: Basic Neurochemistry, 5th ed. GJ Siegel, BJ Agranoff, RW Albers, and PB Molinoff (eds), Raven Press, New York. 181-208. 1994.
88. Young VR and Ajami AM. Glutamate: An Amino acid of particular distinction. J Nutr. 130: 892S-900S. 2000.
89. Collingridge GL and Singer W. Excitatory amino acid receptors ana synaptic plasticity. Trends Pharmacol Sci. 11: 290-296. 1990.
90. Collingridge GL and Bliss TVP. Memories of NMDA receptors and LTP. Trends Neurosci. 18: 54-56. 1995.
91. Fitsanakis VA and Aschner M. The importance of glutamate, glycine, and gamma-aminobutyric acid and regulation in manganese, mercury, and lead neurotoxicity. Toxicol Appl Pharmacol. 204: 343-354. 2005.
92. Baker DA, Xi ZX, Shen H, Swanson CJ, and Kalivas PW. The origin and neuronal function of in vivo nonsynaptic glutamate. J Neurosci. 22: 9134-9141. 2002.
93. Blakely RD, Robinson MB, Guarda AS, and Coyle JT. A re-examination of the interaction of N-acetyl-L-aspartyl-L-glutamate with a subpopulation of rat brain membrane L-[3H]glutamate bidding sites. Eur J Pharmacol. 151: 419-426. 1988.
94. Nicholls D. Amino acids as neurotransmitters. In: Proteins, Transmitters and Synapses. D Nicholls (ed). Blackwell Science, Cambridge. 155-185. 1994.
95. Jackson PF and Slusher BS. Design of NAALAdase inhibitors: a novel neuroprotective strategy. Curr Med Chem. 8: 949-957. 2001.
96. Danbolt NC. Glutamate uptake. Prog Neurobiol. 65: 1-105. 2001.
97. Butcher SP, Sandberg M, Hagberg H, and Hamberger A. Cellular origins of endogenous amino acids released into the extracellular fluid of the rat striatum during severe, insulin-induced hypoglycemia. J Neurochem. 48: 722-723. 1987.
98. Rockhold RW, Acuff CG, and Clower BR. Excitotoxin-induced myocardial necrosis. Eur J Pharmacol. 166: 571-576. 1989.
99. Watters MR. Organic neurotoxins in seafoods. Clin Neurol Neurosurg. 97: 119-124. 1995.
100. Winter CR and Baker RC. L-Glutamate induced changes in intracellular calcium oscillation frequency through non-classical glutamate receptor binding in cultured rat myocardial cells. Life Sci. 57: 1925-1934. 1996.
101. Erdö SL. Excitatory amino acid receptors in the mammalian periphery. Trends Pharmacol Sci. 12: 426-429. 1991.
102. Olney JW. Glutamate, a neurotoxic transmitter. J Child Neurol. 4: 218-26. 1989.
103. Olney JW. Excitotoxins in foods. NeuroToxicology. 15: 535-544. 1994.
104. Marc RE, Liu W-LS, Kalloniatis M, Raiguel SF, and Van Haesendonck E. Patterns of glutamate immunoreactivity in the goldfish retina. J Neurosci. 10: 4006-4034. 1990.
105. Aizenman E, Frosch MP, and Lipton SA. Responses mediated by excitatory amino acid receptors in solitary retinal ganglion cells from rat. J Physiol. 396: 75-91. 1988.
106. Zhou ZJ, Fain GL, and Dowling JE. The excitatory and inhibitory amino acid receptors on horizontal cells isolated from the white perch retina. J Neurophysiol. 70: 8-19. 1993.
107. Sasaki T and Kaneko A. L-glutamate-induced responses in OFF-type bipolar cells of the cat retina. Vision Res. 36: 787-795. 1996.
108. Yudkoff M, Daikhin Y, Nissim I, Horyn O, Lazarow A, Luhovyy B, Wehrli S, and Nissim. I. Response of brain amino acid metabolism to ketosis. Neurochem Int. 47: 119-128. 2005.
109. Watford M. Glutamine and glutamate metabolism across the liver sinusoid. J Nutr. 130: 983S-987S. 2000.
110. Reeds PJ, Burrin DG, Stoll B, and Jahoor F. Intestinal glutamate metabolism. J Nutr. 130: 978S-982S. 2000.
111. Brosnan JT. Glutamate, at the interface between amino acid and carbohydrate metabolism J Nutr. 130: 988S-990S. 2000.
112. Munro HN. Factors in the regulation of glutamate metabolism: In: Glutamic Acid: Advances in Biochemistry. LJ Filer, S Garattini, MR Kare, WA Reynolds and RJ Wurtman (eds). Ravon Press, New York. 55-68. 1979.
113. Garattini S. Glutamic acid, twenty years later. J Nutr. 130: 901S-909S. 2000.
114. Oliet SH, Piet R, and Poulain DA. Control of glutamate clearance and synaptic efficacy by glial coverage of neurons. Science. 292: 923-926. 2001.
115. Jahr CE and Lester RA. Synaptic excitation mediated by glutamate-gated ion channels. Curr Opin Neurobiol. 2: 270-274. 1992.
116. Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP, and Amara SG. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci. 14: 5559-5569. 1994.
117. Malandro MS and Kilberg MS. Molecular biology of mammalian amino acid transporters. Annu Rev Biochem. 65: 305-336. 1996.
118. Bai Y, Hájek P, Chomyn A, Chan E, Seo BB, Matsuno-Yagi A, Yagi T, and Attardi G. Lack of complex I activity in human cells carrying a mutation in MtDNA-encoded ND4 subunit is corrected by the Saccharomyces cerevisiae NADH-quinone oxidoreductase (NDI1) gene. Biol Chem. 276: 38808-38813. 2001.
119. Moriyama Y and Yamamoto A. Glutamatergic chemical transmission: Look! Here, there, and anywhere. J Biochem (Tokyo). 135: 155-163. 2004.
120. Bode BP. Recent molecular advances in mammalian glutamine transport. J Nutr. 131: 2475S-2485S. 2000.
121. Gill SS and Pulido OM. Glutamate receptors in peripheral tissues: excitatory transmission outside of the CNS. Kluwer Academic/Plenum Publishers. New York. 2005.
122. Wantanabe M, Mishina M, and Inoue Y. Distinct gene expression of the N-methyl-D-aspartate receptor channel subunit in peripheral neurons of the mouse sensory ganglia and adrenal gland. Neurosci Lett. 165: 183-186. 1994.
123. Aas P, Tanso R, and Fonnum F. Stimulation of peripheral cholinergic nerves by glutamate indicates a new peripheral GluR. Eur J Pharmacol. 164: 93-102. 1989.
124. Coggeshall RE and Carlton SM. Ultrastructural analysis of NMDA, AMPA, and kainate receptors on myelinated and unmyelinated axons in the periphery. J Comp Neuro. 391: 78-86. 1998.
125. Demenes D, Lleixa A, and Dechesne CJ. Cellular and subcellular localization of AMPA-selective glutamate receptors in the mammalian peripheral vestibular system. Brain Res. 671: 83-94. 1995.
126. Sasa M, Takeshita S, Amano T, and Kutisu K. Primary neurotransmitters and regulatory substances onto vestibular nucleus neurons. Biol Sci Space. 15: 371-374. 2001.
127. Marc RE and Lam DMK. Uptake of aspartic and glutamic acid by photoreceptors in goldfish retina. Proc Natl Acad Sci. 78: 7185-7189. 1981.
128. Tachibana M and Kaneko A. L-glutamate-induced depolarization in solitary photoreceptors: a process that may contribute to the interaction between photoreceptors in situ. Proc Natl Acad Sci. 85: 5315-5319. 1988.
129. Eliasof S and Werblin F. Characterization of the glutamate transporter in retinal cones of the tiger salamander. J Neurosci. 13: 402-411. 1993.
130. Yang X-L and Wu SM. Coexistence and function of glutamate receptor subtypes in the horizontal cells of the tiger salamander retina. Vis Neurosci. 7: 377-382. 1991.
131. Yang JH and Wu SM. Characterization of glutamate transporter function in the tiger salamander retina. Vision Res. 37: 827-838. 1997.
132. Yamaguchi I, Jose PA, Mouradian M, Canessa LM, Monsma FJ, Sibley DR, Takeyasu K, and Felder RA. Expression of dopamine D1A receptor in proximal tubule of rat kidneys. Am J Physiol, 264: F280-F285. 1993.
133. Kiyama H, Sato K, and Tohyama M. Characteristic localization of non-NMDA type glutamate receptor subunits in the rat pituitary gland. Mol Br Res. 19: 262-268. 1993.
134. Mick G. Non-N-methyl-D-aspartate glutamate receptors in glial cells and neurons of the pineal gland in a higher primate. Neuroendocrinology. 61: 256-264. 1995.
135. Barb CR, Campbell RM, Armstrong JD, and Cox NM. Aspartate and glutamate modulation of growth hormone secretion in the pig: Possible site of action. Domestic Animal Endocrinol. 13: 81-90. 1996.
136. Bertrand G, Gross R, Puech R, Loubatieres-Mariana MM, and Bockaert J. Evidence for a glutamate receptor of the AMPA subtype which mediates insulin release from rat perfused pancreas. Br J Pharmacol. 106: 354-359. 1992.
137. Bertrand G, Gross R, Puech R, Loubatieres-Mariana MM, and Bockaert J. Glutamate stimulates glucagon secretion via an excitatory amino acid receptor of the AMPA subtype in rat pancreas. Br J Pharmacol. 237: 45-50. 1993.
138. Gonoi T, Mizuno N, Inagaki N, Kuromi H, Seino Y, Miyazaki J, and Seino S. Functional neuronal ionotropic glutamate receptors are expressed in the non-neuronal cell line MIN6. J Biol Chem. 269: 16989-16992. 1994.
139. Hardy M. Younkin D, Tang CM, Pleasure J, Shi QY, Williams M, and Pleasure D. Expression of non-NMDA glutamate receptor channel genes by clonal human neurons. J Neurochem. 63: 482-489. 1994.
140. Inagaki N, Kuromi H, Gonoi T, Okamoto Y, Ishida H, Seino Y, Kaneko T, Iwanaga T and Seino S. Expression and role of ionotropic glutamate receptors in pancreatic islet cells. FASEB J. 9: 686-691. 1995.
141. Lindstrom P and Ohlsson L. Effects of N-Methyl-DL-aspartate on isolated rat somatotrophs. Endocrinology. 131: 1903-1907. 1992.
142. Liu M-T, Rothstein JD, Gershon MD, and Kirchgessner F. Glutamatergic enteric neurons. J Neurosci. 17: 4764-4784. 1997.
143. Molnar E, Varadi A, McIlhinney RAJ, and Ashcroft SJH. Identification of functional ionotrophic glutamate receptor proteins in the pancreatic β cells and in the islets of Langerhans. FEBS Lett. 371: 253-257. 1995.
144. Weaver CD, Yao TL, Powers AC, and Verdoorn TA. Differential expression of glutamate receptor subtypes in rat pancreatic islets. J Biol Chem. 271: 12977-12984. 1996.
145. Hayashi M, Morimoto R, Yamamoto A, and Moriyama Y. Expression and localization of vesicular glutamate transporters in pancreatic islets, upper gastrointestinal tract and testis. J. Histochem Cytochem. 51: 1375-1390. 2003.
146. Hayashi Y, Yamada H, Uehara S, Morimoto R, Muroyama A, Yatsushiro S, Takeda J, Yamamoto A, and Moriyama Y. Secretory granule-mediated co-secretion of L-Glutamate and glucagons triggers glutaminergic signal transmission in islets of Langerhans. J Bio Chem. 278: 1966-1974. 2003.
147. Pulido O, Veinot J, Mueller Z, Kavanagh M, Rousseaux CG, and Gill, S. Toxicologic Pathology of Glutamate Receptors (GluRs) - An opportunity for pharmaceutical development. Part I - Human Heart. Cardiovascular Toxicologic Pathology: Safety Assessment and Risk Management, STP Annual General Meeting, Washington, DC June 2005.
148. Chaudhari N, Yang H, Lamp C, Delay E, Cartford C, Than T, and Roper, S. The taste of monosodium. glutamate: Membrane receptors in taste buds. J Neurosci. 16: 3817-3826. 1996.
149. Hayashi Y, Zviman MM, Brand JG, Teeter JH, and Restrepo, D. Measurement of membrane potential and [Ca2+] in cell ensembles: Application to the study of glutamate taste in mice. Biophys J. 71: 1057-1070. 1996.
150. Gill S, Veinot J, Kavanagh M, and Pulido O. Human heart glutamate receptors - implications for toxicology, food safety, and drug discovery. Toxicol Pathol. 35: 411-417. 2007.
151. Burns GA, Stephens KE, and Benson JA. Expression of mRNA for Nmethyl-D-aspartate (NMDAR 1) receptor by the enteric neurons of the rat. Neurosci Lett. 170: 87-90. 1994.
152. O'Connell DP, Aherne AM, Lane E, Felder RA, and Carey RM. Detection of dopamine receptors D1A subtype-species c mRNA in rat kidney by in situ hybridization. Am J Physiol. 275: F232-F241. 1998.
153. Stumer T, Amar M, Harvey RJ, Bermudez I, Minnen JV, and Darlison MG. Structure and pharmacological properties of a molluscan glutamategated cation channel and its likely role in the feeding behavior. J Neurosci. 16: 2869-2880. 1996.
154. Moroni F, Luzzi S, Micheli SF, and Zilleti L. The presence of N-methyl-D-aspartate type receptors for glutamic acid in the guinea pig myentericplexus. Neurosci Lett. 68: 57-62. 1986.
155. Shannon HE and Sawyer BD. Glutamate receptors of the N-methyl-Daspartate subtype in the myentric plexus of the guinea pig ileum. J Pharmacol Exp Ther. 251: 518-523. 1989.
156. Sninsky CA, Brooderson RJ, Broome TA, and Bergeron RJ. Evidence for an N-methyl-D-aspartate (NMDA) receptor in the GI tract of guinea pigs: Studies with diethythomospermine (DEHSPM). Gastroenterol. 106: A569. 1994.
157. Gill SS, Pulido OM, Mueller RW and McGuire PF. Molecular and immunochemical characterization of the ionotropic glutamate receptors in the rat heart. Brain Res Bull. 46: 429-434. 1998.
158. Genever PG, Wilkinson DJP, Patton AJ, Peet NM, Hong Y, Mathur A, Erusalimsky JD and Skerry TM. Expression of a functional N-methyl-Daspartate-type glutamate receptor by bone marrow megakaryocytes. Blood. 93: 2876-2883. 1999.
159. Haxhiu MA, Erokwu B, and Dreshaj IA. The role of excitatory amino acids in airway reflex responses in anaesthetized dogs. J Auton Nerv Sys. 67: 192-199. 1997.
160. Said SI. Glutamate receptors and asthmatic airway disease. Trends Biochem Sci. 20: 132-135. 1999.
161. Gill SS, Pulido OM, Mueller RW, and McGuire PF. Immunological characterization of the metabotrophic glutamate receptors in the rat heart. Brain Res Bull. 48: l143-146. 1999.
162. Morhenn VB, Waleh NS, Mansbridge JN, Unson D, Zolotorev A, Cline P, and Toll L. Evidence for an NMDA receptor subunit in human keratinocytes and rat cardiocytes. Eur J Pharmacol. 268: 409-414. 1994.
163. Pulido OM, Veinot J, Mueller R, Kavanagh M, Rousseaux CG, and Gill, S. Human heart glutamate receptors (GluRs) - possible effector sites: An opportunity for drug discovery. Joint International Meeting of the Japanese Society of Toxicologic Pathology and the International Federation of Societies of Toxicologic Pathology, Kobe, Japan, February 2004.
164. Chenu C, Serre CM, Raynal C, Burt-Pichat B and Delmas PD. Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone. 22: 295-299. 1998.
165. Carlton SM, Hargett GL, and Coggeshall RE. Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin. Neurosci Lett. 197: 25-28. 1995.
166. Kanai Y, Bhide PG, DiFiglia M, and Hediger MA. Neuronal high-affinity glutamate transport in the rat central nervous system. Neuroreport. 6: 2357-2362. 1995.
167. Kanai Y, Smith CP, and Hediger MA. A new family of neurotransmitter transporters: the high-affinity glutamate transporters. FASEB J. 8: 1450-1459. 1994.
168. Kanai Y, Trotti D, Nussberger S, and Hediger MA. The high-affinity glutamate transporter family, structure, function, and physiological relevance. In: Neurotransmitter Transporters: Structure, Function, and Regulation. MEA Reith (ed). Humana Press, Totowa, NJ. 171-213. 1997.
169. Kanai Y and Hediger MA. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature. 360: 467-471. 1992.
170. Pines G, Danbolt NC, Bjoras M, Zhang Y, Bendahan A, Eide L, Koepsell H, Storm-Mathisen J, Seeberg E, and Kanner BI. Cloning and expression of a rat brain L-glutamate transporter. Nature. 360: 464-467. 1992.
171. Fairman WA, Vandengerg RJ, Arriza JL, Kavanaugh MP, and Amara SG. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature. 375: 599-603. 1995.
172. Schultz K and Stell WK. Immunocytochemical localization of the high-affinity glutamate transporter, EAAC1, in the retina of representative vertebrate species Neurosci Lett. 211: 191-194. 1996.
173. Arriza JL, Eliasof S, Kavanaugh MP, and Amara SG. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci. 94: 4155-4160. 1997.
174. Brew H and Attwell D. Electrogenic glutamate uptake is a major current carrier in the membrane of axolotl retinal glial cells. Nature. 327: 707-709. 1987.
175. Schwartz EA and Tachibana M. Electrophysiology of glutamate and sodium co-transport in a glial cell of the salamander retina. J Physiol. 426: 43-80. 1990.
176. Barbour B, Brew H, and Attwell D. Electrogenic uptake of glutamate and aspartate into glial cells isolated from the salamander (Ambystoma) retina. J Physiol. 436: 169-193. 1991.
177. Barbour B, Brew H, and Attwell D. Electrogenic glutamate uptake in glial cells is activated by intracellular potassium. Nature. 335: 433-435. 1988.
178. Bouvier M, Szatkowski M, Amato A, and Attwell D. The glial cell glutamate uptake carrier countertransports pH-changing ions. Nature. 360: 471-474. 1992.
179. Naito S and Ueda T. Adenosine triphosphate-dependent uptake of glutamate into Protein I-associated synaptic vesicles. J Biol Chem. 258: 696-699. 1983.
180. Tabb JS and Ueda T. Phylogenetic studies on the synaptic vesicle glutamate transporter. J Neurosci. 11: 1822-1828. 1991.
181. Fykse EM and Fonnum F. Amino acid neurotransmission: dynamics of vesicular uptake. Neurochem Res. 21: 1053-1060. 1996.
182. Picaud SA, Larsson HP, Grant GB, Lecar H, and Werblin FS. Glutamate-gated chloride channel with glutamate-transporter-like properties in cone photoreceptors of the tiger salamander. J Neurophysiol. 74: 1760-1771. 1995.
183. Grant GB and Werblin FS. A glutamate-elicited chloride current with transporter-like properties in rod photoreceptors of the tiger salamander. Vis Neurosci. 13: 135-144. 1996.
184. Grant GB and Dowling JE. A glutamate-activated chloride current in cone-driven ON bipolar cells of the white perch retina. J Neurosci. 15: 3852-3862. 1995.
185. Grant GB and Dowling JE. ON bipolar cell responses in the teleost retina are generated by two distinct mechanisms. J Neurophysiol. 76: 3842-3849. 1996.
186. Roberts E and Frankel S. Gamma-aminobutyric acid in brain: its formation from glutamic acid. J Biol Chem. 187: 55-63. 1950.
187. Awapara J, Landua A, Fuerst R, and Seale B. Free gamma-aminobutyric acid in brain. J Biol Chem. 187: 35-39. 1950.
188. Erlander MG and Tobin AJ. The structural and functional heterogeneity of glutamic acid decarboxylase: a review. Neurochem Res. 16: 215-226. 1991.
189. Otsuka J, Iversen LL, Hall ZW, and Kravitz EA. Release of gamma-aminobutyric acid from inhibitory nerves of lobster. Proc Natl Acad Sci USA. 56: 1110-1115. 1966.
190. Krnjevic K. Chemical nature of synaptic transmission in vertebrates. Physiol Rev. 54: 418-540. 1974.
191. Roberts E. GABA: the road to neurotransmitter status. In: Benzodiazepine/ GABA Receptors and Chloride Channels: Structural and Functional Properties. RW Olsen and CJ Venter (eds). Alan R Liss, New York. 1-39. 1986.
192. Walters RJ. Excitation and adrenaline: GABA - the biopolar neurotransmitter. Cell Sci. 1: 20-22. 2004.
193. Guastella J, Nelson N, and Nelson H. Cloning and expression of a rat brain GABA transporter. Science. 249: 1303-1306. 1990.
194. Borden LA, Smith KE, Hartig PR, Branchek TA, and Weinshank RL. Molecular heterogeneity of the gamma-aminobutyric acid (GABA) transport system. J Biol Chem. 267: 21098-21104. 1992.
195. Gill SS, Veinot J, Mueller R, Kavanagh M, Rousseaux CG, and Pulido OM. Toxicologic Pathology of glutamate receptors (GluRs)-an opportunity for pharmaceutical development. Part II: Inflammation and lymphoid organs. Toxicol. Pathol. 34: P29. 2006.
196. Bleich S, Romer K, Wiltfang J, and Kornhuber J. Glutamate and the glutamate receptor system: a target for drug action. Int J Geriatr Psychiatry. 18: S33-S40. 2003.
197. Chebib M and Johnston GAR. The "ABC" of GABA receptors: A brief review. Clin Exper Pharmacol Physiol. 26: 937. 1999.
198. Boormann JJ. Electrophysiology of GABAA and GABAB receptor subtypes. Trends Neurosci. 11: 112-116. 1988.
199. Boormann JJ. The "ABC" of GABA receptors. Trends Pharmacol Sci. 21: 16-19. 2000.
200. Barnard EA, Darlison MG, and Seeburg P. Molecular biology of the GABAA receptor: the receptor channel superfamily. Trends Neurosci. 10: 502-509. 1987.
201. Olsen RW and Tobin AJ. Molecular biology of GABAA receptors. FASEB J. 4: 1469-1480. 1990.
202. Chen G, Trombley PQ, and van den Pol AN. GABA receptors precede glutamate receptors in hypothalamic development; differential regulation
203. Bertrand PP and Galligan JJ. Alfaxalone, pentobarbital and diazepam potentiate gamma-aminobutyric acid-induced depolarizations in single myenteric neurons of guinea pig intestine. J Pharmacol Exp Ther. 262: 677-682. 1992.
204. Schofield PR, Darlison MG, and Fujita N. Sequence and functional expression of the GABAA receptor shows a ligand gated receptor superfamily. Nature. 328: 221-227. 1987.
205. Macdonald RL and Twyman RE. Biophysical properties and regulation of GABAA receptor channels. Semin Neurosci. 3: 219-230. 1991.
206. Curtis DR, Duggan AW, Felix D, and Johnston GAR. GABA, bicuculline and central inhibition. Nature. 226: 1222-1224. 1970.
207. Haefely W, Kulcsar A, Mohler H, Pieri L, Polc P, and Schaffner R. Possible involvement of GABA in the central actions of benzodiazepines. In: Mechanism of Action of Benzodiazepines. E Costa and P Greengard (eds). Raven Press, New York. 131-151. 1975.
208. Haefely W. The GABA-benzodiazepine interaction fifteen years later. Neurochem Res. 15: 169-174. 1990.
209. Breier A and Paul SM. Anxiety and the benzodiazepine-GABA receptor complex. In: Handbook of Anxiety. M Roth, R Noyes, and GC Burrows (eds). Elsevier, Amsterdam. 1988.
210. Guidotti A, Forchetti C, Corda M, Kondel D, Bennett C, and Costa E. Isolation, characterization and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci USA. 80: 3531-3535. 1983.
211. Majewska MD, Harrison NL, Schwartz RD, Barker JL, and Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 232: 1004-1007. 1986.
212. Paul SM and Purdy RH. Neuroactive steroids. FASEB J. 6: 2311-2322. 1992.
213. 35S]t-Butylbicyclophosphorothionate binds with high affinity to brain specific sites coupled to γ-aminobutyric acid-A and ion recognition sites. Mol Pharmacol. 23: 326-336. 1983.
214. Suzdak PD, Schwartz RD, Skolnick P, and Paul SM. Ethanol stimulates g-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes. Proc Natl Acad Sci USA. 83: 4071-4075. 1986.
215. Neale JH, Bzdega T, and Wroblewska B. N-acetylaspartylglutamate: The most abundant peptide neurotransmitter in the mammalian central nervous system. J Neurochem. 75: 443-452. 2000.
216. Weight FF, Aguayo LG, and White G. GABA- and glutamate-gated ion channels as molecular sites of alcohol and anesthetic action. In: GABAergic Synaptic Transmission. G Biggio, A Concas and E Costa (eds). Raven Press, New York. 335-347. 1992.
217. Burt DR and Kamatchi GL. GABAA receptor subtypes: from pharmacology to molecular biology. FASEB J. 5: 2916-2923. 1991.
218. Pritchett DB, Sontheimer H, and Borman CM. Transient expression shows ligand gating and allosteric potentiation of GABAA receptor subunits. Science. 242: 1306-1308. 1988.
219. Pritchett D, Sontheimer H, and Shivers BD. Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature. 338: 582-585. 1989.
220. Pritchett DB, Lüddens H, and Seeburg P. Type I and type II GABAA benzodiazepine receptors produced in transfected cells. Science. 245: 1389-1392. 1989.
221. Lüddens H, Pritchett DB, and Köhler M. Cerebellar GABAA receptor selective for a behavioral alcohol antagonist. Nature. 346: 648-651. 1990.
222. Lüddens H and Wisden W. Function and pharmacology of multiple GABAA receptor subunits. Trends Pharmacol Sci. 12: 49-51. 1991.
223. Johnston GA. GABA receptors: as complex as ABC? Clin Exp Pharmacol Physiol. 21: 521-526. 1994.
224. Andrade R, Malenka RC, and Nicoll RA. A G-protein couples serotonin and GABAB receptors to the same channels in hippocampus. Science. 234: 1261-1265. 1986.
225. Castelli MP, Ingianna A, Stefanini E, and Gess GL. Distribution of GABAB receptors mRNAs in the rat brain and peripheral tissues. Life Sci. 64: 1321-1328. 1999.
226. Lehninger AL, Nelson DL, and Cox WW. Principles of Biochemistry, 4th ed. WH Freedman & Co., New York. 2004.
227. Borowsky B, Mezey E, and Hoffman BJ. Two glycine transporter variants with distinct localization in the CNS and peripheral tissues are encoded by a common gene. Neuron. 10: 851-863. 1993.
228. Guastella J, Brecha N, Weigmann C, Lester H, and Davidson N. Cloning, expression, and localization of a rat brain high-affinity glycine transporter. Proc Natl Acad Sci USA. 89: 7189-7193. 1992.
229. Paul SM. GABA and glycine. Publications - amino acids. Am College Neuropsychopharmacol. 2000. http://www.acnp.org/G4/GN401000008/ CH008.html (accsessed 2007/06/17)
230. Betz H. Structure and function of inhibitory glycine receptors. Q Rev Biophys. 25: 381-394. 1992.
231. Betz H. Ligand-gated ion channels in the brain: the amino acid receptor superfamily. Neuron. 5: 383-392. 1990.
232. Vandenberg RJ, Handford CA, and Schofield PR. Distinct agonist- and antagonist-binding sites on the glycine receptor. Neuron. 3: 491-496. 1992.
233. Becker C-M. Disorders of the inhibitory glycine receptor: the spastic mouse. FASEB J. 4: 2767-2774. 1990.
234. Betz H and Becker C-M. The mammalian glycine receptor: biology and structure of a neuronal chloride channel protein. Neurochem Int. 13: 137-146. 1988.
235. Young AB and Snyder SH. Strychnine binding in rat spinal cord membranes associated with the synaptic glycine receptor: cooperativity of glycine interactions. Mol Pharmacol. 10: 790-809. 1974.
236. Danysz W and Parsons CG. Glycine and N-methyl-D-aspartate receptors: Physiological significance and possible therapeutic applications. Pharmacol Rev. 50: 597-664. 1998.
237. Supplisson S and Bergman C. Control of NMDA receptor activation by a glycine transporter co-expressed in Xenopus oocytes. J Neurosci. 17: 4580-4590. 1997.
238. Nakanishi S. Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. Neuron. 13: 1031-1037. 1994.
239. Narahashi T, Arakawa O, and Brunner EA. Modulation of GABA receptor-channel complex by alcohols and general anesthetics. In: GABAergic synaptic Transmission. G Biggio, A Concas and E Costa (eds). New York: Raven Press. 325-334. 1992.
240. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 258: 597-603. 1992.
241. Takamori S, Rhee JS, Rosenmund C, and Jahn R. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature. 407: 189-194. 2000.
242. Kew JN and Kemp JA. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl). 179: 4-29. 2005.
243. Harrington EP, Moddel G, Najm IM, and Baraban SC. Altered glutamate receptor - transporter expression and spontaneous reizures in rats exposed to methylazoxymethanol in utero. Epilepsia. 48: 158-168. 2007.
244. Krizbai IA, Deli MA, Pestenácz A, Siklós L, Szabó CA, András I, and Joó F. Expression of glutamate receptors on cultured cerebral endothelial cells. J Neurosci Res. 54: 814-819. 1998.
245. Howe JR. How glutamate receptors are built. Neuroscientist. 5: 311-323. 1999.
246. Mayer ML and Armstrong N. Structure and function of glutamate ion channels. Ann Rev Physiol. 66: 161-181. 2003.
247. Yuzaki M. New New insights into the structure and function of glutamate receptors: the orphan receptor D2 reveals its family's secrets. Keio J Med. 52: 92-99. 2003.
248. McFeeters RL and Oswald RE. Emerging structural explanations of ionotropic glutamate receptor function. FASEB J. 18: 428-438. 2004.
249. Wisden W and Seeburg PH. Mammalian ionotropic glutamate receptors. Curr Opin Neurobiol. 3: 291-298. 1993.
250. McBain CJ and Mayer ML. N-methyl-D-aspartic acid receptor structure and function. Physiol Rev. 74: 723-760. 1994.
251. Danysz W and Parsons CG. NMDA receptor antagonists - multiple modes of action on learning processes. Behav Pharmacol. 6: 619. 1995.
252. 2+ -signalling patterns by NAADP in pancreatic acinar cells. Nature. 398: 74-76. 1999.
253. Rosenmund C, Stern Bach Y, and Stevens CF. The tetrameric structure of a glutamate receptor channel. Nature. 280: 1596-1599. 1998.
254. Laube B, Kuhse J, and Betz H. Evidence for a tetrameric structure of recombinant NMDA receptors, J Neurosci. 18: 2954-2961. 1998.
255. Mansour M, Nagarajan N, Nehring RD, Clements JD, and Rosenmund C. Heteromeric AMPA receptors assemble with a preferred subunit stoichiometry and spatial arrangement. Neuron. 32: 841-853. 2001.
256. Yoneda Y, Kuramoto N, Kitayama T, and Hinoi E. Consolidation of transient ionotropic glutamate signals through nuclear transcription factors in the brain. Prog Neurobiol. 63: 697-719. 2001.
257. Asztely F and Gustafasson B. Ionotropic glutamate receptors: Their possible role in the expression of hippocampal synaptic plasticity. Mol Neurobiol. 12: 1-11. 1996.
258. Rao VR and Finkbeiner S. NMDA and AMPA receptors: old channels, new tricks, Trends Neurosci. 30: 284-291. 2007.
259. Keinanen K, Wisden W, Sommer B, Werner P, Herb A, Versoorn TA, Sakmann B, and Seeburg PH. A family of AMPA-selective glutamate receptors. Science. 249: 556-560. 1990.
260. Verdoorn TA, Burnashev N, Monyer H, Seeburg PH, and Sakmann B. Structural determinants of ion flow through recombinant glutamate receptor channels. Science. 252: 1715-1718. 1991.
261. Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, Masu M, and Nakanishi S. Molecular characterization of the family of N-methyl-D-aspartate receptor subunits. J Biol Chem. 268: 2836-2843. 1993.
262. Moyner H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lorneli H, Burnashev N, Sakmann B, and Seeburg PH. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science. 256: 1217-1221. 1992.
263. Clarke VRJ, Ballyk BA, Hoo KH, Mandelzys A, Pellizzari A, Bath CP, Thomas J, Sharpe EF, Davies CH, Ornstein PL, Schoepp DD, Kamboj RK, Collingridge GL, Lodge D, and Bleakman D. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature. 389: 599-603. 1997.
264. Malenka RC. Synaptic plasticity in the hippocampus. LTP and LTD. Cell. 78: 535-538. 1994.
265. Bear MF and Malenka RC. Synaptic plasticity: LTP and LTD. Curr Opin Neurobiol. 4: 389-399. 1994.
266. Edwards FA. LTP - a structural model to explain the inconsistencies. Trends Neurosci. 18: 250-255. 1995.
267. Rison RA and Stanton PK. Long-term potentiation and N-Methyl-D-Aspartate receptors: foundations of memory and neurologic disease? Neurosci Biobehav Rev. 19: 533-552. 1995.
268. Baudry M. Similarities and contrasts between cerebellar LTD and hippocampal LTP. Behav Brain Sci. 19: 435. 1996.
269. Jeffery KJ. LTP and spatial learning - Where to next? Hippocampus. 7: 95-110. 1997.
270. Herron CE, Lester RAJ, Coan EJ, and Collingridge GL. Frequency-dependent involvement of NMDA receptors in the hippocampus: a novel synaptic mechanism. Nature. 322: 265-269. 1986.
271. Abraham WC and Tate WP. Metaplasticity: A new vista across the field of synaptic plasticity. Prog Neurobiol. 52: 303-323. 1997.
272. Grant SGN and Silva AJ. Targeting learning. Trends Neurosci. 17: 71-75. 1994.
273. Lisman J. The CAM kinase II hypothesis for the storage of synaptic memory. Trends Neurosci. 17: 406-412. 1994.
274. Partin KM, Patneau DK, Winters CA, Mayer ML, and Buonanno A. Selectivc modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin-A. Neuron. 11: 1069-1082. 1993.
275. Benowitz LI and Routtenberg A. GAP-43: An intrinsic determinant of neuronal development and plasticity. Trends Neurosci. 20: 84-91. 1997.
276. Lan JY, Skeberdis VA, Jover T, Grooms SY, Lin Y, Araneda RC, Zheng X, Bennett MV, and Zukin RS. Protein kinase C modulates NMDA receptor trafficking and gating. Nat Neurosci. 4: 382-390. 2001.
277. Bayer KU, De Koninck P, Leonard AS, Hell JW, and Schulman H. Interaction with the NMDA receptor locks CaMKII in an active conformation. Nature. 411: 801-805. 2001.
278. Maren S, Tocco G, Standley S, Baudry M, and Thompson RF. Postsynaptic factors in the expression of long-term potentiation (LTP) - increased glutamate receptor binding following LTP induction in vivo. Proc Natl Acad Sci USA. 90: 9654-9658. 1993.
279. Ambros-Ingerson J and Lynch G. Channel gating kinetics and synaptic efficacy - a hypothesis for expression of long-term potentiation. Proc Natl Acad Sci USA. 90: 7903-7907. 1993.
280. Ambros-Ingerson J, Xiao P, Larson J, and Lynch G. Waveform analysis suggests that LTP alters the kinetics of synaptic receptor channels. Brain Res. 620: 237-244. 1993.
281. Benke TA, Luthi A, Isaac JTR, and Collingridge GL. Modulation of AMPA receptor unitary conductance by synaptic activity. Nature. 393: 793-797. 1998.
282. Kessler M, Arai A, Vanderliksh P, and Lynch G. Failure to detect changes in ampa receptor binding after long-term potentiation. Brain Res. 560: 337-341. 1991.
283. Che YH, Tamatani M, and Tohyama M. Changes in mRNA for post-synaptic density-95 (PSD-95) and carboxy-teminal PDZ ligand of neuronal nitric oxide synthase following facial nerve transection. Brain Res Mol Brain Res. 76: 325-335. 2000.
284. Lynch MA. Mechanisms underlying induction and maintenance of long-term potentiation in the hippocampus. Bioessays. 10: 85-90. 1989.
285. Odell TJ, Hawkins RD, Kandel E R, and Arancio O. Tests of the roles of 2 diffusible substances in long-term potentiation - Evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci USA. 88: 11285-11289. 1991.
286. Kato K, Clark GD, Bazan NG, and Zorumski CF. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation.. Nature. 367: 175-179. 1994.
287. Kato K, Uruno K, Saito K, and Kato H. Both arachidonic acid and 1-oleoyl-2-acetyl glycerol in low magnesium solution induce long-term potentiation in hippocampal CA1-neurons in vitro. Brain Res. 563: 94-100. 1991.
288. Schaechter JD and Benowitz LI. Activation of protein kinase-c by arachidonic acid selectively enhances the phosphorylation of GAP-43 in nerve terminal membranes. J Neurosci. 13: 4361-4371. 1993.
289. Luo Y and Vallano ML. Arachidonic acid, but not sodium nitroprusside, stimulates presynaptic protein kinase C and phosphorylation of GAP-43 in rat hippocampal slices and synaptosomes. J Neurochem. 64: 1808-1818. 1995.
290. Artola A and Singer W. Long-term depression of excitatory synaptic transmission and its relationship to long-term potentiation. Trends Neurosci. 16: 480-487. 1993.
291. Christie BR, Kerr DS, and Abraham WC. Flip side of synaptic plasticity: long-term depression mechanisms in the hippocampus. Hippocampus. 4: 127-135. 1994.
292. Cummings JA, Mulkey RM, Nicoll RA, and Malenka RC. Ca(2+) signaling requirements for long-term depression in the hippocampus. Neuron. 16: 825-833. 1996.
293. Derrick BE and Martinez Jr JL. Associative, bidirectional modifications at the hippocampal mossy fibre-CA3 synapse. Nature. 381: 429-434. 1996.
294. 2+](i) have to be reached to induce LTP and LTD in neocortical pyramidal cells. J Physiol - Paris. 90: 317-319. 1996
295. Kirkwood A, Rioult MG, and Bear W. Experience-dependent modification of synaptic plasticity in visual cortex. Nature. 381: 526-528. 1996.
296. Tsumoto T, Yasuda H, Fukuda M, and Akaneya Y. Postsynaptic calcium and calcium-dependent processes in synaptic plasticity in the developing visual cortex. J Physiol Paris. 90: 151-156. 1996.
297. Tsumoto T and Yasuda H. A switching role of postsynaptic calcium in the induction of long-term potentiation or long-term depression in visual cortex. Semin Neurosci. 8: 311-319. 1996.
298. Christie BR, Magee JC, and Johnston D. Dendritic calcium channels and hippocampal long-term depression. Hippocampus. 6: 17-23. 1996.
299. Artola A, Hensch T, and Singer W. Calcium-induced long-term depression in the visual cortex of the rat in vitro. J Neurophysiol. 76: 984-994. 1996.
300. Bannerman DM, Good MA, Butcher SP, Ramsay M, and Morris RGM. Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature. 378: 182-186. 1995.
301. Saucier D and Cain DP. Spatial learning without NMDA receptor-dependent long-term potentiation. Nature. 378: 186-189. 1995.
302. Morris RGM. Further studies of the role of hippocampal synaptic plasticity in spatial learning: Is hippocampal LTP a mechanism for automatically recording attended experience? J Physiol - Paris. 90: 333-334. 1996.
303. Stricker C, Field AC, and Redman SJ. Changes in quantal parameters of EPSCs in rat CA1 neurones in vitro after the induction of long-term potentiation. J Physiol. 490: 443-454. 1996a.
304. Stricker C, Field AC, and Redman SJ. Statistical analysis of amplitude fluctuations in EPSCs evoked in rat CA1 pyramidal neurones in vitro. J Physiol. 490: 419-441. 1996.
305. Isaac JTR, Hjelmstad GO, Nicoll RA, and Malenka RC. Long-term potentiation at single fiber inputs to hippocampal CA1 pyramidal cells. Proc Natl Acad Sci USA. 93: 8710-8715. 1996.
306. Isaac JTR, Oliet SHR, Hjelmstad GO, Nicoll RA, and Malenka RC. Expression mechanisms of long-term potentiation in the hippocampus. J Physiol - Paris. 90: 299-303. 1996.
307. Manabe T and Nicoll RA. Long-term potentiation: evidence against an increase in transmitter release probability in the CA1 region of the hippocampus. Science. 265: 1888-1892. 1994.
308. Liao DZ, Hessler NA, and Malinow R. Activation of postsynaptically silent synapses during pairing-induced LTP in CA1 region of hippocampal slice. Nature. 375: 400-404. 1995.
309. Nicotera P and Lipton SA. Excitotoxins in neuronal apoptosis and necrosis. J Cereb Blood Flow Metab. 19: 583-591. 1999.
310. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi Lomeli H, Burnashev N, Shakmann B, and Seeburg P. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science. 256: 1217-1221. 1992.
311. Montgomery JM, Pavlidis P, and Madison DV. Pair recordings reveal all-silent synaptic connections and the postsynaptic expression of long-term potentiation. Neuron. 29: 691-701. 2001.
312. Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, Yan Z, Sagawa ZK, Ouimet CC, Nairn AC, Nestler EJ, and Greengard P. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature. 410: 376-380. 2001.
313. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, and Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature. 354: 31-37. 1991.
314. Sharp CD, Hines I, Warren JH, Jackson IV, Jawahar A, Nanda A, Elrod JW, Long A, Chi A, Minagar A, and Alexander JS. Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor. Am J Physiol Heart Circ Physiol. 285: H2592-H2598. 2003.
315. Katsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, Megure H, Masaki H, Kumanishi T, Arakawa M, and Mishina M. Molecular diversity of the NMDA receptor channel. Nature. 358: 36-41. 1992.
316. Chenard BL and Menniti FS. 1999. Antagonists selective for NMDA receptors containing the NR2B subunit. Curr Pharmaceut Design. 5: 381-404.
317. Mayer ML and Westbrook GL. Permeation and block of N-Methyl-D-Aspartic acid receptor channels by divalent cations in mouse cultured central neurones. J Physiol. 394: 501-527. 1987.
318. Lodge D. Subtypes of glutamate receptors. Historical perspectives on their pharmacological differentiation. In: The Ionotropic Glutamate Receptors. DT Monaghan and RJ Weinhold (eds). Humana Press, New Jersey. 1-38: 1997
319. +2 antagonize NMDA and GABA responses of hippocampal neurons. Nature. 328: 640-643. 1987.
320. 3H]MK-801 binding to the N-Methyl-D-Aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines. J Neurochem. 51: 830-836. 1988.
321. Williams K, Zappia AM, Pritchett DB, Shen YM, and Molinoff PB. Sensitivity of the N-Methyl-D-Aspartate receptor to polyamines is controlled by NR2 subunits. Mol Pharmacol. 45: 803-809. 1994.
322. Johnson JW and Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 325: 529-531. 1987.
323. Kleckner NW and Dingledine R. Requirement for glycine activation of NMDA-receptors expressed in Xenopus oocytes. Science. 241: 835-837. 1988.
324. Nowak L, Bregestovski P, Ascher P, Herbet A, and Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature. 307: 462-465. 1984.
325. Kirchoff F. NDMA receptor in glia. Neuroscientist. 13: 28-37. 2007.
326. Hirai H, Kirsch J, Laube B, Betz H, and Kuhse J. The glycine binding site of the N-methyl-D-aspartate receptor subunit NR1: identification of novel determinants of coagonist potentiation in the extracellular m3-m4 loop region. Proc Natl Acad Sci. 93: 6031-6036. 1996.
327. Laube B, Hirai H, Sturgess M, Betz H, and Kuhse J. Molecular determinants of agonist discrimination by NMDA receptor subunits: Analysis of the glutamate binding site on the NR2B subunit. Neuron, 18: 493-503. 1997.
328. Salt TE. Glutamate receptor functions in sensory relay in the thalamus. Philos Trans R Soc Lond B Biol Sci. 357: 1759-1766. 2002.
329. Laurie DJ, Putzke J, Zieglgansberger W, Seeburg PH, and Tolle TR. The distribution of splice variants of the NMDAR1 subunit mRNA in adult rat brain. Mol Brain Res. 32: 94-108. 1995.
330. Sucher NJ, Awobuluyi M, Choi YB, and Lipton SA. NMDA receptors: from genes to channels. Trends Pharmacol Sci. 17: 348-355. 1996.
331. Tolle TR, Berthele A, Zieglgansberger W, Seeburg PH, and Wisden W. The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J Neurosci. 13: 5009-5028. 1993.
332. Sundstrom E, Whittemore S, Mo LL, and Seiger A. Analysis of NMDA receptors in the human spinal cord. Exp Neurol. 148: 407-413. 1997.
333. Sucher NJ, Akbarian S, Chi CL, Leclerc CL, Awobuluyi M, Deitcher DL, Wu MK, Yuan JP, Jones EG, and Lipton SA. Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-1) in the rodent brain. J Neurosci. 15: 6509-6520. 1995.
334. Kinsley CH, Madonia L, Gifford GW, Tureski K, Griffin GR, Lowry C, Williams J, Collins J, McLearie H, and Lambert KG. Motherhood improves learning and memory. Nature. 402: 137-138. 1999.
335. Matsuda K, Kamiya Y, Matsuda S, and Yuzaki M. Cloning and characterization of a novel NMDA receptor subunit NR3B: a dominant subunit that reduces calcium permeability, Brain Res Mol Brain Res. 100: 43-52. 2002.
336. Chatterton JE, Awobuluyi M, Premkumar LS, Takahashi H, Talantova M, Shin Y, Cui J, Tu S, Sevarino KA, Nakanishi N, Tong G, Lipton SA, and Zhang D. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature. 415: 793-798. 2002.
337. Chavez AE, Singer JH, and Diamond JS. Fast neurotransmitter release triggered by Ca influx through AMPA-type glutamate receptors. Nature. 443: 705-708. 2006.
338. Bowie D and Mayer ML. Inward rectification of both AMPA and kainate subtype glutamate receptors generated by polyamine-mediated ion channel block. Neuron. 15: 453-462. 1995.
339. Kawai F and Sterling P. AMPA receptor activates a G-protein that suppresses a cGMP-gated current. J Neurosci. 19: 2954-2959. 1999.
340. Partin KM, Fleck MW, and Mayer ML. AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate. J Neurosci. 16: 6634-6647. 1996.
341. Parsons CG, Zong XG, and Lux HD. Whole cell and single channel analysis of the kinetics of glycine-sensitive N-methyl-D-aspartate receptor desensitization. Br J Pharmacol. 109: 213-221. 1993.
342. Sommer B, Keinanen K, Verdoorn TA, Wisden W, Burnashev N, Herb A, Kohler M, and Takagi T. Flip and Flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science. 249: 1580-15. 1990.
343. Lerma J, Paternain AV, and Rodriguez-Moreno A. Molecular physiology of kainate receptors. Physiol Rev. 81: 971-998. 2001.
344. Vignes M, Bleakman D, Lodge D, and Collingridge GL. The synaptic activation of the GluR5 subtype of kainate receptor of in area CA3 of the rat hippocampus. Neuropharmacol. 36: 1477-1481. 1997.
345. Chittajallu R, Braithwaite SP, Clarke VR, and Henley JM. Kainate receptors: subunits, synaptic localization and function. Trends Pharmacol Sci. 20: 26-35. 1999.
346. Schmitz D, Mellor J, and Nicoll RA. Presynaptic kainate receptor mediation of frequency facilitation at hippocampal mossy fiber synapses. Science. 291: 1972-1976. 2001.
347. Contractor A, Swanson G, and Heinemann SF. Kainate receptors are involved in short and long-term plasticity at mossy fiber synapses in the hippocampus. Neuron. 29: 209-216. 2001.
348. 3H] gamma aminobutyric acid release by kainate receptor activation in rat hippocampal synaptosomes. Eur J Pharmacol. 323: 167-172. 1997.
349. Abram SE and Olson EE. Systemic opioids do not suppress spinal sensitization after subcutaneous formalin in rats. Anesthesiology. 80: 1114-1119. 1994.
350. Wilding TJ and Huettner JE. Activation and desensitization of hippocampal kainate receptors. J Neurosci. 17: 2713-2721. 1997.
351. Lerma J, Morales M, Vicente MA, and Herreras O. Glutamate receptors of the kainate type and synaptic transmission. Trends Neurosci. 20: 9-12. 1997.
352. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, Jingami H, and Morikawa K. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature. 407: 971-977. 2000.
353. Wang JQ, Mao L, Parelkar NK, Tang Q, Liu Z, Sarwar S, and Choe ES. Glutamate-regulated behavior, transmitter release, gene expression and addictive plasticity in the striatum: roles of metabotropic glutamate receptors. Curr Neuropharmacol. 1: 1-20. 2003.
354. Couthinho V and Knoepfel T. Metabotropic glutamate receptors: electrical and chemical signaling properties. Neuroscientist. 8: 551-561. 2002.
355. Gilbertson TA, Scobey R, and Wilson M. Permeation of calcium ions through non-NMDA glutamate channels in retinal bipolar cells, Science 251: 1613-1615. 1991.
356. Boos R, Schneider H, and, Wasslee H. Voltage- and transmitter-gated currents of All amacrine cells in a slice preparation of the rat retina. J Neurosci. 13: 2874-2888. 1993.
357. Cohen ED and Miller RF. The role of NMDA and non-NMDA excitatory amino acid receptors in the functional organization of primate retinal ganglion cells. Vis Neurosci. 11: 317-332. 1994.
358. Yu W and Miller RF. NBQX, an improved non-NMDA antagonist studied in retinal ganglion cells. Brain Res. 692: 190-194. 1995.
359. Yamada KA and Tang C-M. Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. J Neurosci. 13: 3904-3915. 1993
360. Kessler M, Arai A, Quan A, and Lynch G. Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: lack of competition between cyclothiazide and GYKI 52466. Molec Pharmacol. 49: 123-131. 1996.
361. Cartmell J and Schoepp DD. Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem. 75: 889-907. 2000.
362. Boulter J, Hollmann M, O'Shea-Greenfield A, Hartley M, Deneris E, Maron C, and Heinemann S. Molecular cloning and functional expression of glutamate receptor subunit genes. Science. 249: 1033-1037. 1990.
363. Hollmann M, O'Shea-Greenfield A, Rogers SW, and Heinemann S. Cloning by functional expression of a member of the glutamate receptor family. Nature. 342: 643-648. 1989.
364. Bettler B, Boulter J, Hermans-Borgmeyer I, O'Shea-Greenfield A, Deneris ES, Moll C, Borgmeyer U, Hollmann M, and Heinemann S. Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development. Neuron. 5: 583-595. 1990.
365. Bettler B, Egebjerg J, Sharma G, Pecht G, Hermans-Borgmeyer I, Moll C, Stevens CF, and Heinemann S. Cloning of a putative glutamate receptor: a low affinity kainate-binding subunit. Neuron. 8: 257-265. 1992.
366. Egebjerg J, Bettler B, Hermans-Borgmeyer I, and Heinemann S. Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA. Nature. 351: 745-748. 1991.
367. Gomes AR, Cunha P, Nuriya M, Faro CJ, Hugnair RL, Pires EV, Carvalho AL, and Duarte CB. Metabotropic glutamate and dopamine receptors co-regulate AMPA receptor activity through PKA in cultured chick retinal neurones: effect on GluR4 phosphorylation and surface expression. J Neurochem. 90: 673-682. 2004
368. Hu G, Duffy P, Swanson C, Ghasemzadeh MB, and Kalivas PW. The regulation of dopamine transmission by metabotropic glutamate receptors. J. Pharmacol Exper Therapeut. 289: 412-416. 1999.
369. Cao C, Tse H, Jane D, Evans R, and Headley P. Antagonism of mGlu receptors and potentiation of EPSCs at rat spinal motoneurones in vitro. Neuropharmacol. 36: 313-318. 1997.
370. Cao C, Tse H, Jane D, Evans R, and Headley P. Metabotropic glutamate receptor antagonists, like GABA(B) antagonists, potentiate dorsal root-evoked excitatory synaptic transmission at neonatal rat spinal motoneurons in vitro. Neuroscience. 78: 243-250. 1997.
371. Dong X-W and Feldman DJL. Distinct subtypes of metabotropic glutamate receptors mediate differential actions on excitability of spinal respiratory motoneurons. J Neurosci. 19: 5173-5184. 1999.
372. Greer JJ, Smith JC, and Feldman JL. Role of excitatory amino acids in the generation and transmission of respiratory drive in neonatal rat. J Physiol. 437: 727-749. 1991.
373. Hennman E and Mendell L. Functional organization of motoneuron pool and its inputs. In: Handbook of Physiology. The Nervous System. Motor Systems. Bethesda, MD. Am Physiol Soc. sect. I, vol. II, pt. 1, chapt. 11, 423-214. 1981.
374. Lynch DR and Guttmann RP. NMDA receptor pharmacology: perspectives from molecular biology. Curr Drug Targets. 2: 215-231. 2001.
375. Hargreaves RJ, Rigby M, Smith D, and Hill RG. Lack of effect of 1-687,414 ((+)-cis-4-methyl-HA-966). an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology. Br J Pharmacol. 110: 36-42. 1993.
376. Murata S and Kawasaki K. Common and uncommon behavioural effects of antagonists for different modulatory sites in the NMDA receptor/channel complex. Eur J Pharmacol. 239: 9-15. 1993.
377. Bristow LJ, Flatman KL, Hutson PH, Kulagowski JJ, Leeson PD, Young L, and Tricklebank MD. The atypical neuroleptic profile of the glycine/ n-methyl-d-aspartate receptor antagonist, 1-701,324, in rodents. J Pharmacol Exp Ther. 277: 578-585. 1996.
378. Kretschmer BD, Kratzer U, Breithecker K, ahd Koch M. ACEA 1021, a glycine site antagonist with minor psychotomimetic and amnestic effects in rats. Eur J. Pharmacol. 331: 109-116. 1997.
379. Baron BM, Harrison BL, Kehne JH, Schmidt CJ, VanGiersbergen PLM, White HS, Siegel BW, Senyah Y, McCloskey TC, Fadayel GM, Taylor VL, Murawsky MK, Nyce P, and Salituro FG. Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist. Eur J Pharmacol. 323: 181-192. 1997.
380. Parsons CG, Danysz W, and Quack G. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacol. 38: 735-767. 1999.
381. Stone TW. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog. Neurobiol. 64: 185-218. 2001.
382. Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, and Albuquerque EX. The brain metabolite kynurenic acid inhibits a1pha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci. 21: 7463-7473. 2001.
383. Karcz-Kubicha, M, Jessa M, Nazar M, Plaznik A, Hartmann S, Parsons CG, and Danysz W. Anxiolytic activity of glycine-B antagonists and partial agonists - No relation to intrinsic activity in the patch clamp. Neuropharmacol. 36: 1355-1367. 1997.
384. Henderson G, Johnson JW, and Ascher P. Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor. J Physiol - London. 430: 189-212. 1990.
385. Kemp JA and Priestley T. Effects of (+)-HA-966 and 7-chlorokynurenic acid on the kinetics of N-methyl-D-asparatate receptor agonist responses in rat cultured cortical neurons. Mol Pharmacol. 39: 666-670. 1991.
386. Lanthorn TH. D-cycloserine: agonist turned antagonist. Amino Acids. 6: 247-260. 1994.
387. Witkin JM, Steele TD, and Sharpe LG. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline. J Pharmacol Exp Ther. 280: 46-52. 1997.
388. Priestley T and Kemp JA. Kinetic study of the interactions between the glutamate and glycine recognition sites on the N-methyl-D-aspartic acid receptor complex. Mol Pharmacol. 46: 1191-1196. 1994.
389. Fossom LH, Basile AS, and Skolnick P. Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition. Mol Pharmacol. 48: 981-987. 1995.
390. Krueger JM, O'Connor AJ, and Kelso SR. Glycine site agonists exhibit subunit specific effects on NMDA receptors expressed in Xenopus oocytes. Soc Neurosci Abst. 23: 945. 1997.
391. Skolnick P, Marvizon JCG, Jackson BW, Monn JA, Pice KC, and Lewin AP. Blockade of N-methyl-D-aspartate induced convulsions by 1-aminocyclopropanecarboxylates. Life Sci. 45: 1647-1656. 1989.
392. Skolnick P, Miller R, Young A, Boje K, and Trullas R. Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complex. Psychopharmacol. 107: 489-496. 1992.
393. Papp and Moryl, 1996 Cited in [Gill SS and Pulido OM. Glutamate receptors in peripheral tissues: excitatory transmission outside of the CNS. Kluwer Academic/Plenum Publishers. New York. 2005].
394. O'Connor AJ, Evalchogiannnis G, and Moskal J. Subunit specific effects of D-cycloserine on NMDA receptor receptors'expressed in Xenopus oocytes. Soc. Neurosci. Abs. 22, #604.15. 1996.
395. Sheinin A, Shavit S, and Benveniste M. Subunit specificity and mechanism of action of NMDA partial agonist, D-cycloserine. Neuropharmacol. 41: 151-158. 2001.
396. Durand GM, Kovalchuk Y, and Konnerth A. Long-term potentiation and functional synapse induction in developing hippocampus. Nature. 381: 71-75. 1996.
397. Rosenmund C, Clements JD, and Westbrook GL. Nonuniform probability of glutamate release at a hippocampal synapse.. Science. 261: 754-757. 1993.